Andrew Seth Sandler
Independent DirectorDr. Andrew Seth Sandler, M.D., serves as Chief Medical Officer of Alpine Immune Sciences, Inc. and was Chief Medical Officer since August 18, 2022 until Dr. Sandler became a director upon the effectiveness of our initial public offering in August 2021. Dr. Sandler served as Chief Medical Officer of Alpine Immune Sciences, Inc. (Nasdaq: ALPN) from August 2022 until June 2024. From September 2017 until June 2022, Dr. Sandler served as Chief Medical Officer at Kiadis Pharma N.V. Prior to Kiadis, Dr. Sandler was Senior Vice President, Medical Affairs at Medivation (acquired by Pfizer) from January 2016 to June 2017. Dr. Sandler held various additional roles including Chief Medical Officer and Seattle Site Head at Dendreon Pharmaceuticals from October 2010 to April 2015. Prior to Dendreon, Dr. Sandler was Chief Medical Officer at Spectrum Pharmaceuticals from September 2008 to April 2010 and Vice President, Head of Global Medical Affairs, Oncology for Bayer Healthcare Pharmaceuticals from February 2008 to February 2010. Dr. Sandler also held various positions at Berlex Oncology/Schering AG from October 2003 to August 2008 and Seagen, Inc. from October 1999 to June 2003. Dr. Sandler was a Fellow in Hematology/Medical Oncology at the University of California, San Francisco (UCSF) from July 1994 to June 1996. He did his Internship, Residency and Chief Residency at Mt. Sinai Hospital in New York, NY from July 1990 to June 1994. Dr. Sandler attended and received his MD degree from Mount Sinai School of Medicine (Icahn School of Medicine at Mt. Sinai) from July 1986 to June 1990. In addition, he graduated from the University of Rochester with a B.S. degree in Neuroscience in 1986. Dr. Sandler was selected as a director due to his experience in the biotechnology and pharmaceutical industries as well as his leadership experience. He served as Medical Director of NexCura, LLC. Dr. Sandler has experience within the healthcare industry and oncology setting. Since October 1, 2017, Dr. Sandler has served as Chief Medical Officer at Kiadis Pharma N.V. Prior to Kiadis, Dr. Sandler was Senior Vice President, Medical Affairs at Medivation (acquired by Pfizer) from January 2016 to June 2017. He served as the Chief Medical Officer and Executive Vice President of Dendreon Corp. since February 1, 2014 and served as its Site Head of The Operations in Seattle from October 2010 to April 2015. He served as Senior Vice President of Global Clinical and Medical Affairs at Dendreon Corp. and joined in 2010. He served as the Chief Medical Officer of Spectrum Pharmaceuticals, Inc. from February 2009 to April 12, 2010. Prior to joining Dendreon, he held senior-level positions with several leading biotechnology and pharmaceutical companies, including Bayer Healthcare, Berlex Oncology/Schering AG from October 2003 to August 2008, Seagen Incorporated from October 1999 to June 2003, Seattle Genetics and Spectrum. Dr. Sandler has been an Independent Director of Dermata Therapeutics, Inc. since August 2021. He served as a Director of the Everett Clinic Center for Cancer Care in Everett. He held positions like Vice President and Head of Global Medical Affairs for Oncology at Bayer Healthcare Pharmaceuticals. Dr. Sandler was a Fellow in Hematology/Medical Oncology at the University of California, San Francisco (UCSF) from July 1994 to June 1996. He did his Internship, Residency and Chief Residency at Mt. Sinai Hospital in New York, NY from July 1990 to June 1994. Dr. Sandler attended and received his MD degree from Mount Sinai School of Medicine (Icahn School of Medicine at Mt. Sinai) from July 1986 to June 1990. In addition, he graduated from the University of Rochester with a B.S. degree in Neuroscience in 1986. Dr. Sandler also holds a Certificate in Epidemiology and Biostatistics.
公司职务
- 公司名称Dermata Therapeutics, Inc.股票代码DRMA职务Independent Director共事同僚
- GTGerald T. ProehlFounder, President, CEO & Chairman
- DFDavid F. HaleCo-Founder & Lead Independent Director
- KKKyri K. Van HooseSenior VP & CFO
- CJChristopher J. NardoSenior VP & Chief Development Officer
- SPSean ProehlAssociate General Counsel
- WDWendell D. WierengaIndependent Director
- KDKathleen D. ScottIndependent Director
